Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers
"The untapped market of proton therapy in Russia would be more than US$ 3 Billion during forecast period. IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, has started installation of the Cyclone® 230 in 2016 for a new proton therapy center. The acceptance of the first treatment room is planned for the end of 2017. The proton therapy center in Dimitrovgrad will be IBA’s first in the Russian Federation and is expected to treat up to 1,200 patients per year according to IBA.
Proton Therapy Market in Russia & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers provides a detailed assessment of the Proton Therapy Market in Russia. In this report we have studied the market in two parts a) Actual Market and b) Untapped Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies.
a) Actual Market is the current market which is already present
b) Untapped Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
Key Questions Answered in the Report?
• What is the Proton Therapy Market in Russia & its growth potential in Future?
• What is the Untapped Proton Therapy Market in Russia and its Future?
• How many Proton Therapy Facilities are operating in Russia?
• How many Proton Therapy Facilities are in construction and planning phase?
• What is the number of people being treated in these Proton Therapy Centers yearly?
• Is Proton Therapy Treatment being covered in the Reimbursement policy of Russia?
• What are the sales of Proton Therapy Companies Globally (IBA, Varian, Elekta)?
Key Companies Covered
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)